46.70
Precedente Chiudi:
$44.01
Aprire:
$43.83
Volume 24 ore:
1.23M
Relative Volume:
1.28
Capitalizzazione di mercato:
$3.69B
Reddito:
$399.58M
Utile/perdita netta:
$-54.04M
Rapporto P/E:
-62.27
EPS:
-0.75
Flusso di cassa netto:
$40.13M
1 W Prestazione:
+18.89%
1M Prestazione:
+27.14%
6M Prestazione:
+71.94%
1 anno Prestazione:
+17.96%
Veracyte Inc Stock (VCYT) Company Profile
Nome
Veracyte Inc
Settore
Industria
Telefono
(650) 243-6300
Indirizzo
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Confronta VCYT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
VCYT
Veracyte Inc
|
46.70 | 3.48B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Iniziato | Canaccord Genuity | Hold |
| 2025-03-20 | Iniziato | Craig Hallum | Buy |
| 2024-12-05 | Downgrade | Goldman | Buy → Neutral |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-10-16 | Iniziato | UBS | Buy |
| 2024-10-10 | Iniziato | Guggenheim | Buy |
| 2024-02-23 | Reiterato | Needham | Buy |
| 2023-01-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2021-11-18 | Ripresa | Goldman | Buy |
| 2021-06-15 | Iniziato | Raymond James | Outperform |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Iniziato | Morgan Stanley | Underweight |
| 2019-07-31 | Iniziato | Lake Street | Buy |
| 2019-07-02 | Iniziato | Needham | Buy |
| 2018-11-29 | Downgrade | Janney | Buy → Neutral |
| 2018-10-31 | Aggiornamento | Janney | Neutral → Buy |
| 2017-11-07 | Downgrade | Janney | Buy → Neutral |
| 2017-11-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Ripresa | BTIG Research | Buy |
| 2016-11-14 | Ripresa | Leerink Partners | Outperform |
| 2015-12-18 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-06-11 | Reiterato | Leerink Partners | Outperform |
| 2013-11-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Veracyte Inc Borsa (VCYT) Ultime notizie
Veracyte Stock Soars Amid Strong Earnings and New Price Targets - timothysykes.com
Veracyte Stock Surges Amid Investor Conferences and Robust Earnings - StocksToTrade
Is Veracyte Inc a good long term investmentMoving Average Crossovers & AI-Based Insights for Consistent Profits - earlytimes.in
Veracyte Stock Soars Amid Revenue and EPS Surprises - timothysykes.com
Veracyte, Inc. (NASDAQ:VCYT) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Insider Sell: Jens Holstein Sells 10,000 Shares of Veracyte Inc (VCYT) - GuruFocus
Veracyte Director Jens Holstein Sells 10,000 Shares - TradingView
Dir Holstein Sells 10,000 ($423.6K) Of Veracyte Inc [VCYT] - TradingView
[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan
Will Veracyte Inc. (12V) stock sustain bullish trend into 2025Earnings Overview Summary & Safe Entry Point Identification - newser.com
Can Veracyte Inc. (12V) stock surprise markets with earningsTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
Veracyte at Stephens Conference: Strategic Growth and Expansion By Investing.com - Investing.com India
Veracyte at Stephens Conference: Strategic Growth and Expansion - Investing.com
Veracyte at Jefferies London: Strategic Expansion and Growth By Investing.com - Investing.com Nigeria
Veracyte at Jefferies London: Strategic Expansion and Growth - Investing.com
Will Veracyte Inc. stock gain from government policiesShort Setup & Weekly High Conviction Trade Ideas - newser.com
Will Veracyte Inc. (12V) stock profit from fiscal stimulus2025 Key Lessons & Capital Efficiency Focused Strategies - newser.com
Can Veracyte Inc. (12V) stock sustain breakout momentumRisk Management & Daily Entry Point Alerts - newser.com
How Veracyte Inc. stock performs in interest rate cyclesPortfolio Return Summary & Daily Profit Focused Screening - newser.com
How to read the order book for Veracyte Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Tools to assess Veracyte Inc.’s risk profileEarnings Beat & AI Enhanced Trading Alerts - newser.com
Is Veracyte Inc. (12V) stock cheap vs fundamentalsGap Down & Verified Momentum Stock Watchlist - newser.com
Heatmap analysis for Veracyte Inc. and competitorsMarket Trend Review & Step-by-Step Trade Execution Guides - newser.com
Veracyte Inc Azioni (VCYT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):